18

Blood Clot Formation

Embed Size (px)

DESCRIPTION

Blood Clot Formation. ATLAS ACS 2—TIMI 51 Design. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. APPRAISE-2. ATLAS-ACS TIMI 46. Newer Antiplatelet Agents. WOEST Efficacy End Points. WOEST Bleeding Events. - PowerPoint PPT Presentation

Citation preview

Page 1: Blood Clot Formation
Page 2: Blood Clot Formation

Blood Clot Formation

Page 3: Blood Clot Formation

ATLAS ACS 2—TIMI 51Design

Page 4: Blood Clot Formation
Page 5: Blood Clot Formation
Page 6: Blood Clot Formation

ATLAS-2Patients With Biomarker Elevation, n =

12,626

Page 7: Blood Clot Formation

ATLAS-2Patients With Biomarker Elevation, n =

12,626

Page 8: Blood Clot Formation

APPRAISE-2

Page 9: Blood Clot Formation

ATLAS-ACS TIMI 46

Page 10: Blood Clot Formation

Newer Antiplatelet Agents

Page 11: Blood Clot Formation

WOESTEfficacy End Points

Page 12: Blood Clot Formation

WOESTBleeding Events

Page 13: Blood Clot Formation
Page 14: Blood Clot Formation
Page 15: Blood Clot Formation
Page 16: Blood Clot Formation
Page 17: Blood Clot Formation
Page 18: Blood Clot Formation